Elmind Capital, LP: 13F holdings
CIK 20522132026Q2
| Positions | 35 |
|---|
| Reported value | $398.0m |
|---|
| Filed | 2026-08-14 |
|---|
Change since last quarter
| Positions | 35 (+1 vs prior quarter) |
|---|
| Reported value | $398.0m (+13.0%) |
|---|
Top 10 holdings
| Security | Shares | Value | Weight |
|---|
| COGT COGENT BIOSCIENCES INC | 1,170,740 | $45.3m | 11.4% |
| SNDX SYNDAX PHARMACEUTICALS INC | 1,855,000 | $40.6m | 10.2% |
| CLDX CELLDEX THERAPEUTICS INC NEW | 990,000 | $36.8m | 9.3% |
| RLAY RELAY THERAPEUTICS INC | 1,465,279 | $27.4m | 6.9% |
| PCVX VAXCYTE INC | 452,340 | $26.3m | 6.6% |
| VERA VERA THERAPEUTICS INC | 436,518 | $18.7m | 4.7% |
| PHARVARIS N V | 525,750 | $18.2m | 4.6% |
| VRDN VIRIDIAN THERAPEUTICS INC | 984,931 | $18.1m | 4.5% |
| CTMX CYTOMX THERAPEUTICS INC. | 4,550,000 | $17.1m | 4.3% |
| TVTX TRAVERE THERAPEUTICS INC | 292,600 | $16.6m | 4.2% |
Get the full book
import finzdata as yf
yf.Client().manager_holdings(cik="2052213")
Every position, quarter by quarter since 2013, with adds, trims and exits, on the look-back bundles.
Get a free API keySee history bundlesDownload free samples